Mesoblast reported $2.33B in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Avita Medical AUD 105.47M 35.32M Dec/2025
Clinuvel Pharmaceuticals AUD 625.5M 105.22M Dec/2025
Cochlear AUD 17.05B 2.6B Dec/2025
CSL USD 55.89B 20.42B Dec/2025
Pacific Edge NZD 177.94M 16.27M Jun/2026
Paradigm Biopharmaceuticals AUD 145.7M 26.92M Dec/2025
PYC Therapeutics AUD 965.3M 209.97M Dec/2025
Ramsay Health Care AUD 7.93B 537.83M Dec/2025
Telix Pharmaceuticals AUD 7.81B 2.74B Jun/2026